HomeCompareOPORF vs PEP

OPORF vs PEP: Dividend Comparison 2026

OPORF yields 3.14% · PEP yields 3.66%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PEP wins by $120.2K in total portfolio value· pulled ahead in Year 3
10 years
OPORF
OPORF
● Live price
3.14%
Share price
$0.09
Annual div
$0.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.5K
Annual income
$384.28
Full OPORF calculator →
PEP
PepsiCo Inc.
● Live price
3.66%
Share price
$155.29
Annual div
$5.69
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$144.7K
Annual income
$63,430.49
Full PEP calculator →

Portfolio growth — OPORF vs PEP

📍 PEP pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodOPORFPEP
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, OPORF + PEP cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
OPORF pays
PEP pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

OPORF
Annual income on $10K today (after 15% tax)
$266.85/yr
After 10yr DRIP, annual income (after tax)
$326.64/yr
PEP
Annual income on $10K today (after 15% tax)
$311.45/yr
After 10yr DRIP, annual income (after tax)
$53,915.92/yr
At 15% tax rate, PEP beats the other by $53,589.28/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of OPORF + PEP for your $10,000?

OPORF: 50%PEP: 50%
100% PEP50/50100% OPORF
Portfolio after 10yr
$84.6K
Annual income
$31,907.39/yr
Blended yield
37.73%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PEP right now

OPORF
No analyst data
Altman Z
3.9
Piotroski
6/9
PEP
Analyst Ratings
1
Strong
15
Buy
28
Hold
1
Sell
Consensus: Hold
Price Target
$172.43
+11.0% upside vs current
Range: $156.00 — $191.00
Altman Z
3.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

OPORF buys
0
PEP buys
0
No recent congressional trades found for OPORF or PEP in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricOPORFPEP
Forward yield3.14%3.66%
Annual dividend / share$0.00$5.69
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4%
Portfolio after 10y$24.5K$144.7K
Annual income after 10y$384.28$63,430.49
Total dividends collected$3.5K$125.7K
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: OPORF vs PEP ($10,000, DRIP)

YearOPORF PortfolioOPORF Income/yrPEP PortfolioPEP Income/yrGap
1$11,014$313.94$10,854$514.44+$160.00OPORF
2$12,108$323.15$11,982$758.21+$126.00OPORF
3← crossover$13,288$332.01$13,526$1,136.44$238.00PEP
4$14,558$340.52$15,727$1,741.93$1.2KPEP
5$15,926$348.67$19,012$2,750.28$3.1KPEP
6$17,397$356.48$24,173$4,514.44$6.8KPEP
7$18,979$363.93$32,789$7,793.80$13.8KPEP
8$20,679$371.05$48,258$14,354.51$27.6KPEP
9$22,504$377.83$78,586$28,686.63$56.1KPEP
10$24,464$384.28$144,688$63,430.49$120.2KPEP

OPORF vs PEP: Complete Analysis 2026

OPORFStock

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model. In addition, the company is developing a database of infectious disease progression data that include Disease in Motion platform, which comprises unique datasets, such as clinical, immunological, virological, and digital (wearable) biomarkers. The Disease in Motion platform has various potential applications across a range of end users, including big technology, wearables, pharma, and biotech companies. Further, the company provides pre­clinical and early clinical research services; sales and marketing services; and biometry, data management, and statistics to its various European pharmaceutical clients, as well as drug development consultancy and services, including CMC (chemistry, manufacturing, and controls), and PK and medical writing to a range of European clients. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.

Full OPORF Calculator →

PEPConsumer Staples

PepsiCo, Inc. manufactures, markets, distributes, and sells various beverages and convenient foods worldwide. The company operates through seven segments: Frito-Lay North America; Quaker Foods North America; PepsiCo Beverages North America; Latin America; Europe; Africa, Middle East and South Asia; and Asia Pacific, Australia and New Zealand and China Region. It provides dips, cheese-flavored snacks, and spreads, as well as corn, potato, and tortilla chips; cereals, rice, pasta, mixes and syrups, granola bars, grits, oatmeal, rice cakes, simply granola, and side dishes; beverage concentrates, fountain syrups, and finished goods; ready-to-drink tea, coffee, and juices; dairy products; and sparkling water makers and related products. It serves wholesale and other distributors, foodservice customers, grocery stores, drug stores, convenience stores, discount/dollar stores, mass merchandisers, membership stores, hard discounters, e-commerce retailers and authorized independent bottlers, and others through a network of direct-store-delivery, customer warehouse, and distributor networks, as well as directly to consumers through e-commerce platforms and retailers. The company was founded in 1898 and is headquartered in Purchase, New York.

Full PEP Calculator →
📬

Get this OPORF vs PEP comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

OPORF vs SCHDOPORF vs JEPIOPORF vs OOPORF vs KOOPORF vs MAINOPORF vs MOOPORF vs PMOPORF vs GIS

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.